EcoR1 Capital’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-641,426
| Closed | -$1.68M | – | 44 |
|
2025
Q1 | $1.68M | Hold |
641,426
| – | – | 0.1% | 37 |
|
2024
Q4 | $2.64M | Sell |
641,426
-1,858,574
| -74% | -$7.66M | 0.1% | 46 |
|
2024
Q3 | $17.7M | Buy |
+2,500,000
| New | +$17.7M | 0.61% | 36 |
|
2023
Q4 | – | Sell |
-4,163,824
| Closed | -$35M | – | 55 |
|
2023
Q3 | $35M | Hold |
4,163,824
| – | – | 1.18% | 17 |
|
2023
Q2 | $52.3M | Hold |
4,163,824
| – | – | 1.28% | 15 |
|
2023
Q1 | $68.6M | Hold |
4,163,824
| – | – | 2.21% | 14 |
|
2022
Q4 | $62.2M | Hold |
4,163,824
| – | – | 1.89% | 14 |
|
2022
Q3 | $93.1M | Buy |
4,163,824
+440,283
| +12% | +$9.85M | 2.75% | 11 |
|
2022
Q2 | $62.4M | Buy |
3,723,541
+1,432,100
| +62% | +$24M | 2.15% | 14 |
|
2022
Q1 | $68.6M | Buy |
2,291,441
+512,357
| +29% | +$15.3M | 2.15% | 15 |
|
2021
Q4 | $54.6M | Buy |
1,779,084
+393,808
| +28% | +$12.1M | 1.74% | 16 |
|
2021
Q3 | $43.7M | Sell |
1,385,276
-3,102,500
| -69% | -$97.8M | 1.52% | 15 |
|
2021
Q2 | $164M | Buy |
4,487,776
+1,058,413
| +31% | +$38.7M | 6.14% | 5 |
|
2021
Q1 | $119M | Buy |
3,429,363
+228,714
| +7% | +$7.91M | 5.26% | 6 |
|
2020
Q4 | $133M | Hold |
3,200,649
| – | – | 7.15% | 2 |
|
2020
Q3 | $136M | Buy |
+3,200,649
| New | +$136M | 9.72% | 3 |
|